LGLIX | VIGAX | LGLIX / VIGAX | |
Total Expense Ratio | 0.65 | 0.05 | 1,300% |
Annual Report Gross Expense Ratio | 0.65 | 0.05 | 1,300% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | 7.347 | 6.330 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.36B | 294B | 3% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 24.54 | 15.68 | 157% |
Returns for 3 years | 88.38 | 93.72 | 94% |
Returns for 5 years | 47.36 | 122.85 | 39% |
Returns for 10 years | 125.88 | 309.30 | 41% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FFPNX | 69.48 | 0.46 | +0.67% |
American Funds New Perspective 529-F-2 | |||
IHOSX | 22.41 | 0.11 | +0.49% |
Hartford International Opportunities R4 | |||
SWRLX | 18.01 | 0.08 | +0.45% |
Touchstone International Value A | |||
FSRBX | 31.40 | -0.04 | -0.13% |
Fidelity Select Banking | |||
ETIHX | 34.10 | -0.05 | -0.15% |
Eventide Healthcare & Life Sciences I |